uniQure N.V. Ordinary Shares vs State Street Real Estate Select Sector SPDR ETF — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while State Street Real Estate Select Sector SPDR ETF trades at $41.82 (market cap $7.75B). The key difference: State Street Real Estate Select Sector SPDR ETF is far larger — about 5.3× uniQure N.V. Ordinary Shares's market cap, and State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and State Street Real Estate Select Sector SPDR ETF for 77 Days on average.
| QURE | XLRE | |
|---|---|---|
Market Cap | $1.45B | $7.75B |
Volume | 3,323,243 | 7,826,350 |
Sector | Health | Sector/Thematic |
52-Week High | $70.59 | $46.01 |
52-Week Low | $9.03 | $40.01 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $707.46M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLRE trades at $41.83, down 0.21% on the day, with a mixed technical outlook showing a bullish overall signal but bearish moving averages. The ETF's expense ratio of 0.08% is a competitive advantage, though key valuation and profitability metrics are unavailable. Recent news highlights its role as a low-cost U.S. real estate ETF, with articles discussing its diversification versus global peers and performance amid interest rate volatility.
The outlook for XLRE is nuanced; it offers cost efficiency and U.S. large-cap real estate exposure, but faces headwinds from elevated interest rates and potential underperformance versus digital infrastructure ETFs. Investment opportunity lies in its income potential and inflation hedging, while risks include rate sensitivity and sector rotation. Analyst sentiment is balanced, reflecting sector-wide uncertainties.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →